MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 14 transactions totaling $194.9M, demonstrating a bullish sentiment with $194.8M in net insider flow. The most recent transaction on Jun 27, 2019 involved a sale of 13,000 shares valued at $72.4K.
No significant insider buying has been recorded for MLNT in the recent period.
No significant insider selling has been recorded for MLNT in the recent period.
Based on recent SEC filings, insider sentiment for MLNT is bullish with an Insider Alignment Score of 100/100 and a net flow of $194.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading MLNT stock, having executed 14 transactions in the past 90 days. The most active insider is Holdings Llc Vatera (Executive), who has made 6 transactions totaling $194.3M.
Get notified when executives and directors at MLNT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 27, 2019 | Johnson John | Executive | Sale | 13,000 | $5.57 | $72.4K | |
| May 22, 2019 | Johnson John | Executive | Option Exercise | 50,000 | $N/A | $0 | |
| May 29, 2018 | Cammarata Sue | Executive | Purchase | 4,000 | $5.00 | $20.0K | |
| May 29, 2018 | Llc Vatera Holdings | Executive | Purchase | 7,878,500 | $5.00 | $39.4M | Large |
| May 29, 2018 | Llc Vatera Holdings | Executive | Purchase | 7,500,000 | $5.00 | $37.5M | Large |
| May 29, 2018 | Llc Vatera Holdings | Executive | Purchase | 7,878,500 | $5.00 | $39.4M | Large |
| May 29, 2018 | Mark Wechsler Daniel | Executive | Purchase | 50,000 | $5.00 | $250.0K | |
| May 29, 2018 | Duffy Erin | Executive | Purchase | 4,000 | $5.00 | $20.0K | |
| May 29, 2018 | Zaccardelli David | Executive | Purchase | 40,000 | $5.00 | $200.0K | |
| May 29, 2018 | Estrem Paul | Executive | Purchase | 10,000 | $5.00 | $50.0K | |
| May 25, 2018 | N. Gill David | Executive | Purchase | 5,000 | $6.09 | $30.4K | |
| Jan 5, 2018 | Llc Vatera Holdings | Executive | Purchase | 1,777,778 | $13.50 | $24.0M | Large |
| Jan 5, 2018 | Llc Vatera Holdings | Executive | Purchase | 2,000,000 | $13.50 | $27.0M | Large |
| Jan 5, 2018 | Llc Vatera Holdings | Executive | Purchase | 2,000,000 | $13.50 | $27.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $194.9M | 100.0% |
Sale(S) | 1 | $72.4K | 0.0% |
Exercise(M) | 1 | $0 | 0.0% |
Insiders at MELINTA THERAPEUTICS, INC. /NEW/ are accumulating shares at an accelerated pace. With 8 insiders making 14 transactions totaling $194.9M in purchases versus $72.4K in sales, the net buying activity of $194.8M signals strong executive confidence. Holdings Llc Vatera (Executive) leads the buying activity with $194.3M in transactions across all time.